Tofogliflozin
- Generic Name
- Tofogliflozin
- Drug Type
- Small Molecule
- Chemical Formula
- C22H26O6
- CAS Number
- 903565-83-3
- Unique Ingredient Identifier
- 554245W62T
- Background
Tofogliflozin has been used in trials studying the treatment and prevention of Diabetes Mellitus Type 2.
SGLT2 Inhibitors Not Cost-Effective for Type 2 Diabetes with Heart Failure in Thailand
• A cost-utility analysis in Thailand found that adding SGLT2 inhibitors to standard care for type 2 diabetes patients with heart failure is not cost-effective at current prices.
• The study suggests price reductions of up to 90% for some SGLT2 inhibitors would be needed to meet Thailand's cost-effectiveness threshold.
• The analysis, using national health data, considered direct medical and non-medical costs from a societal perspective, unlike previous studies.
• Canagliflozin showed the lowest incremental cost-effectiveness ratio, but its efficacy data relies on a post-hoc analysis with limited heart failure patients.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath